IVIg Treatment Reduces Catalytic Antibody Titers of Renal Transplanted Patients - Mahendra, Ankit; Peyron, Ivan; Dollinger, Cécile; Gilardin, Laurent; Sharma, Meenu; Wootla, Bharath; Padiolleau-Lefevre, Séverine; Friboulet, Alain; Boquet, Didier; Legendre, Christophe; Kaveri, Srinivas V.; Thaunat, Olivier; et al. (PloS one, 2013)
Keywords: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Catalytic - blood; Antibodies, Catalytic - metabolism; Autoantibodies - blood; Autoantibodies - immunology; Biology; Care and treatment; Catalysis; Catalytic antibodies; Desensitization; End-stage renal disease; Engineering Sciences; Enzymatic activity; Enzymes; Female; Graft rejection; Graft Rejection - immunology; Health aspects; Hemophilia; Histocompatibility Antigens - immunology; Humans; Hydrolysis; Immunoglobulin G; Immunoglobulin G - blood; Immunoglobulin G - metabolism; Immunoglobulins; Immunoglobulins, Intravenous - administration & dosage; Immunology; Immunosuppression; Immunosuppressive agents; Inflammatory diseases; Intravenous administration; Kidney diseases; Kidney Transplantation; Lymphocytes; Male; Medical prognosis; Medical research; Medicine; Middle Aged; Nephrology; Nephropathy; Other; Patients; Peptides; Prognosis; Reduction; Rejection; Renal failure; Rodents; Transplantation; Transplants & implants; Young Adult; France